Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)
Recruiting · NCT06958991 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Histolog Scanner
What this trial is about
The clinical performance study is collecting data from the use of a CE mark product used within the scope of its intended purpose to intraoperatively visualize tissue specimen. The subjects are not submitted to invasive and burdensome procedures compared to the standard of care surgical practices and regular use of the CE mark product.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult female Subject ≥18 years old.
- Subject scheduled for breast conserving surgery of invasive and/or in-situ ductal and lobular carcinoma.
- Subject is able to read, understand and sign the informed consent.
Exclusion criteria
- Subject with planned mastectomy
- Subject does not speak French- Subject with planned tumor-adapted breast reduction
- Subject is pregnant/ lactating. Subjects pregnant/lactating are excluded because such subjects are presenting additional risks during the surgery and they are also rare.
- Participation in any other clinical study that would affect data acquisition.
Where it is running
1 location listed.
- HFR - Villars-sûr-glâne, Canton of Fribourg, Switzerland